Drug-development efforts are always fraught with promise and peril. Today, more than half of all investigational drugs in Phase III clinical trials fail 1, due to factors such as flawed design, inappropriate endpoints, safety issues, lack of funding, failure to […]
Read More
“Encourage your kids to be data scientists,” Jane Quigley, senior VP, digital health, at PRA Health Sciences, offered. Considered one of the “godmothers of real-world data (RWD),” Quigley was underscoring the need today—and great opportunity amid the convergence of technology […]
Read More
Driverless cars and doctorless diagnosticians must work flawlessly every time. Likewise, their users must be confident that such artificial intelligence (AI)-driven innovations will work as expected. Adoption of these technologies—and, hence, their tremendous benefits—hinges on trust. It is a catch-22. […]
Read MoreA recent report by Deloitte projects that the artificial intelligence (AI) drug discovery market will grow 53% by 2025, citing the increased investment of labs in AI as a way to boost research but also to collect, analyze, and produce […]
Read More
Since March, when the majority of the US was placed on lockdown and began limiting in-person interactions, the healthcare and pharmaceutical industry has learned much about prioritizing patients and healthcare providers (HCPs). Meeting these populations’ needs, especially in times of […]
Read MoreThe quest to simulate human intelligence in machines has introduced numerous industries to the power of artificial intelligence (AI). In the healthcare and pharmaceutical settings, the past few years have witnessed the advancement and adoption of AI platforms, most notably, […]
Read MoreThe FDA identifies more than 20,000 prescription drug products as approved for marketing, and there are approximately 900,000 active physicians in the US who can prescribe those drugs. Accounting for all of the pharmaceutical products that ultimately reach patients requires […]
Read MoreImagine this hypothetical scenario, which is not farfetched in the life sciences industry. Let us assume there is a safety event in a market due to a contaminated drug product and the health authority in that market issues a recall. […]
Read More
